OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Conventional and robotic automation inside closed systems reduces risk.
Evolving equipment designs meet the needs of continuous processing techniques.
Stability programs for biologics are far more complex than small-molecule drugs.
Reformulation strategies are useful tools for more than just stretching out return on investment.
Almost half of pharmaceutical industry profits continue to come from biopharmaceuticals.
AstraZeneca’s AZD7442 Clinical Trial Meets Primary Endpoint
Pharma strategizes to reduce its environmental footprint while optimizing output.
October 19, 2021
The council voted 19-0 to recommend that FDA authorize booster doses of the J&J COVID-19 vaccine just one day after granting Moderna a similar recommendation.
October 18, 2021
The Pharmaceutical Technology and BioPharm International editors host industry experts in serialization and aseptic processing.
Evonik’s LIPEX Flow extruder is a new version of its high-pressure equipment for manufacturing liposomal drug products.
October 15, 2021
The council voted 19–0 to recommend that FDA authorize booster doses of the Moderna COVID-19 vaccine for certain populations.
In this collaboration, Takeda will utilize Poseida's biodegradable DNA and RNA nanoparticle delivery technology and other proprietary genetic engineering platforms for the research and development of gene therapies.
MilliporeSigma announced the opening of its second Carlsbad, California-based facility, which doubles production capacity to support commercial and industrial manufacturing of viral vectors.
After months of deliberation, Biden plans to appoint cardiologist Robert Califf as FDA commissioner.
Back in person at the Javits Center, exhibitors present containers, components, equipment, and services to fill, ship, protect, and optimize the packaging process.
October 14, 2021
Aceto will acquire A&C Bio Buffer, including the company’s custom buffer and chemical blend portfolio.
Pharmalex has launched the Biopharma Excellence brand, a new service line that combines the expertise of PharmaLex, ERA Consulting, and Biopharma Excellence.